SurgeryPartners and Nike

Why Nike is the Ideal Owner for Surgery Partners Over TPG or UHC

As the healthcare industry continues to see strategic consolidations, the latest buzz revolves around TPG and UnitedHealth Group (UHC), two industry titans vying to acquire Surgery Partners, a leading musculoskeletal (MSK) provider.

Currently, Bain Capital owns a 39% stake in the company. However, another potential buyer could bring an entirely different dynamic to the table: Nike.

While traditionally viewed as a sports and apparel giant, Nike’s brand equity, global reach, and natural synergy with musculoskeletal care make it a potentially transformative owner for Surgery Partners. Nike, rather than TPG or UHC, could be the best fit for Surgery Partners and the future of MSK healthcare.

Nike is far more than a footwear and apparel company; it’s a globally recognized and trusted brand for athleticism, performance, and health.

With Surgery Partners’ focus on musculoskeletal treatments, including orthopedics and sports medicine, Nike’s entry into healthcare could bring unmatched brand credibility. It would allow Nike to seamlessly extend its influence from footwear into healthcare services, turning its name into a trusted source for athletic equipment, injury recovery, and prevention.

By contrast, TPG, a private equity giant, and UHC, a leader in insurance, lack Nike’s global emotional connection with athletes and health-conscious consumers. Nike’s status as a worldwide leader would elevate Surgery Partners and introduce a new dimension to healthcare, where brand loyalty could be a significant driver of patient trust and growth.

The U.S. spends some $420 billion annually on musculoskeletal conditions, with the global spend exceeding $1 trillion. Surgery Partners’ focus on orthopedic and MSK procedures positions it squarely within this massive market. For Nike, which has built its brand around enhancing athletic performance, investing in the MSK space would be a natural extension of its mission.

Sports medicine and orthopedics are already integral to Nike’s ecosystem. By acquiring Surgery Partners, Nike could offer athletes and active individuals a complete health journey—from performance to recovery—under a single brand. This would benefit Nike’s core customer base and open the door to partnerships with elite sports organizations and institutions globally, extending its influence beyond apparel and into comprehensive healthcare solutions.

Conversely, TPG and UHC may view Surgery Partners primarily through a financial or healthcare cost-containment lens. However, Nike could bring a more holistic, patient-centered approach, leveraging its unique athletic performance and wellness expertise to revolutionize MSK care.

While healthcare consolidations often prioritize financial synergies, Nike has the chance to do something fundamentally different with Surgery Partners. By incorporating orthopedics and sports medicine under the Nike brand, the company could become the go-to provider for athletes and physically active individuals worldwide.

For elite athletes, having access to Nike-branded recovery centers could be a game-changer. Athletes are unlikely to seek treatment at generic facilities like OrthoABC or St. Francis Health System when given a choice. But Nike Orthopedics? That’s a name that resonates. For athletes, rehab and treatment centers carrying the Nike swoosh could become as essential as their gear. The brand already has global relationships with athletes, which it could easily leverage into a premier healthcare network.

The MSK healthcare space is ripe for innovation. The sector remains one of global healthcare’s most significant expense categories, with orthopedic procedures being a critical cost driver. Nike’s potential to reimagine and brand these services could lead to improved patient outcomes and substantial new revenue streams.

While UHC would likely seek to integrate Surgery Partners into its existing insurance model—focusing on cost efficiency—Nike could focus on value creation by aligning healthcare services with its broader consumer base. In doing so, Nike could tap into premium services aimed at athletes and active consumers, positioning itself as a leader in MSK innovation while avoiding the commoditization trap that often occurs in healthcare mergers led by insurance companies.

TPG, on the other hand, would likely prioritize short-term profitability, relying on traditional private equity strategies such as cutting costs and improving operational efficiency. However, with its strong balance sheet and long-term brand focus, Nike has the potential to unlock growth in ways that neither UHC nor TPG can match.

Nike’s influence in the sports world is undeniable, and the idea of top orthopedic surgeons and healthcare providers working under the Nike banner is not far-fetched. By acquiring Surgery Partners, Nike could attract the world’s best orthopedic specialists, creating a healthcare network that stands head and shoulders above its competitors.

Working within the Nike ecosystem could offer physicians an unparalleled opportunity to align with a globally respected brand while engaging in cutting-edge medical innovation. The appeal of being associated with a brand that represents performance, excellence, and innovation would likely drive recruitment of the top talent in the medical field.

Ultimately, the question comes down to vision. TPG and UHC will focus on optimizing the bottom line, but Nike can approach healthcare differently. It can revolutionize the patient experience, making orthopedic care more accessible, aspirational, and brand-aligned. For patients, the idea of being treated by Nike—a brand that has long been associated with excellence—could foster trust and loyalty that healthcare systems traditionally struggle to build.

Nike’s entry into the healthcare space would be a bold move that could redefine its brand and the MSK care landscape. By acquiring Surgery Partners, Nike has the chance to evolve beyond its roots and become a leader in sports and global healthcare. The potential to bring world-class musculoskeletal care under a globally trusted brand is an opportunity neither TPG nor UHC can replicate.

While private equity and insurance companies may see value in Surgery Partners’ strong MSK focus, only Nike has the brand power, athletic connections, and global reach to transform the future of musculoskeletal healthcare truly.

-Rojas out